Lizheng Wu
No ORCID on file
· 16 papers in corpus
· active 2022-2026
Study types
- article 12
- other 4
Condition tags
- endometriosis 16
Top journals
Frequent coauthors
- Fang-Li Pei 16
- Cheng Zeng 16
- Jin-Jin Jia 14
- Zi-Jun Kuang 13
- Rui Su 12
- Xiao-Xin Chen 4
- Bo-Wen Sun 4
- Shu-Hong Lin 3
- Dan-Tong Lan 2
- Shi‐Yuan Zhang 2
article
2026
Supplementary Material 1: 14 herbs of LSNYP.
article
2026
Supplementary Material 1: 14 herbs of LSNYP.
article
2026
Supplementary Material 2: 114 Potential active components.
article
2026
Supplementary Material 2: 114 Potential active components.
article
2026
Supplementary Material 3: 217 potential therapeutic targets.
article
2026
Supplementary Material 3: 217 potential therapeutic targets.
article
2026
Supplementary Material 4: Main quality control components were identified by UHPLC-Q/TOF-MS.
article
2026
Supplementary Material 4: Main quality control components were identified by UHPLC-Q/TOF-MS.
other
2026
BACKGROUND: Luoshi Neiyi prescription (LSNYP) is a traditional Chinese medicine that has a clinical effect on endometriosis (EMs). This study combined network pharmacology with experimental validation to explore its potential molecular mech…
other
2026
Abstract Background Luoshi Neiyi prescription (LSNYP) is a traditional Chinese medicine that has a clinical effect on endometriosis (EMs). This study combined network pharmacology with experimental validation to explore its potential molecu…
other
2026
Abstract Background Luoshi Neiyi prescription (LSNYP) is a traditional Chinese medicine that has a clinical effect on endometriosis (EMs). This study combined network pharmacology with experimental validation to explore its potential molecu…
article
2024
Background: Endometriosis (EM) is a long-lasting inflammatory disease that is difficult to treat and prevent. Existing research indicates the significance of immune infiltration in the progression of EM. Efferocytosis has an important immun…
article
2024
ETHNOPHARMACOLOGICAL RELEVANCE: Endometriosis (EMS) is a common gynecological disease that causes dysmenorrhea, chronic pelvic pain and infertility. Luoshi Neiyi Prescription (LSNYP), a traditional Chinese medicine (TCM) formula, is used to…
article
2024
This study investigated the effect of Luoshi Neiyi Formula(LSNYF) on hypoxia-inducible factor-1α(HIF-1α) and steroidogenic factor 1(SF-1) in endometriosis(EMs), aiming to explore the mechanism of Luoshi Neiyi Formula in treating EMs. Immuno…
other
2024
INTRODUCTION: Endometriosis (EMs) is characterized by ectopic growth of active endometrial tissue outside the uterus. The Luoshi Neiyi prescription (LSNYP) has been extensively used for treating EMs in China. However, data on the active che…
article
2022
Network Meta-analysis was performed to systematically compare the efficacy of different Chinese patent medicines for activating blood and resolving stasis in the treatment of endometriosis and to provide evidence-based references for clinic…